The US Food and Drug Administration (FDA) has given green signal to first medical device that aims to treat migraine headaches.
A nerve-stimulating headband received the approval by FDA as the first medical device to prevent migraine headaches.
According to the FDA, the device provides a new trustable option for patients having unbearable migraine medications.
The new migraine prevention device, Cefaly, is a battery-powered plastic band worn across the forehead. It is manufactured by Cephaly Technology of Belgium.
The band with the help of an adhesive electrode emits a low electrical current to stimulate nerves associated with migraine pain. It gives you a tingling sensation on the skin where the electrode is applied. The device should not be used more than 20 minutes a day by patients who are 18 years and older.
For finding the feedback of the device, FDA carried study on 67 people with problem of migraine. The study showed that the patients using the device experienced fewer migraines per month than others patients using a placebo device. The Cefaly headband did not completely eliminate migraine headaches or reduce the intensity of migraines that occurred. FDA also found no serious adverse events or side effects after using the device.
In another study, about 53 percent of 2,313 patients involved with it said they were satisfied with the device and were willing to purchase it for future use.